NCT00235014View on ClinicalTrials.gov

A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,204

Participants

Timeline

Start Date

March 31, 1997

Primary Completion Date

January 31, 2006

Conditions
HypertensionDiabetes
Interventions
DRUG

trandolapril

2 mg QD

DRUG

trandolapril/verapamil

180/2 mg QD

DRUG

placebo

1 tablet QD

DRUG

verapamil

SR 240 mg QD

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY